数据链接：
官方服务：
资源简介：
Actionable drug targets in glioblastoma.
应用场景：
创建时间：
2022-03-24
相关数据集
Synthesis and Preclinical Validation of Novel Indole Derivatives as a GPR17 Agonist for Glioblastoma Treatment
The discovery of a potential ligand-targeting G protein-coupled receptor 17 (GPR17) is important for developing chemotherapeutic agents against glioblastoma multiforme (GBM). We used the integration o
Figshare2021-07-26 更新80
Synthesis and Bioevaluation of 3‑(Arylmethylene)indole Derivatives: Discovery of a Novel ALK Modulator with Antiglioblastoma Activities
Glioblastoma is the most common brain tumor, with high recurrence and low survival rates. An integrative bioinformatics analysis demonstrated that anaplastic lymphoma kinase (ALK) is a promising thera
NIAID Data Ecosystem20
Transcription profiling of human cytokine induced A172 glioblastoma cells treated with erstressin and nostressin
Transcription profiling of human cytokine induced A172 glioblastoma cells treated with erstressin and nostressin
ChEBI2008-06-15 更新10
High-throughput 3D glioblastoma model for rapid personalized therapeutic screening
Glioblastoma (GBM) is a devastating brain tumor with limited therapeutic success, largely due to the inability to pre-test patient-specific responses to treatment in a reliable and timely manner with
NIAID Data Ecosystem40
DataSheet1_Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion.PDF
Glioblastoma multiforme (GBM) is the most common and malignant brain tumor, and almost half of the patients carrying EGFR-driven tumor with PTEN deficiency are resistant to EGFR-targeted therapy. EGFR
NIAID Data Ecosystem20
